Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-006398

Options or other derivatives

  • Chief Accounting Officer & VP acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Monohon Ted Chief Accounting Officer & VP 2023-02-01 Grant or award · Employee Stock Option (right to buy) +110,000 110,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…